Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2008-06-03
2008-06-03
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C564S165000
Reexamination Certificate
active
07381750
ABSTRACT:
A compound of the formula (I) wherein the variables X1, X2, R1to R7including R3′, j, k, p, y, and z, are as defined or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed.
REFERENCES:
patent: 5965741 (1999-10-01), Breault et al.
patent: 6410561 (2002-06-01), Shinkai et al.
patent: 1 504 604 (1978-03-01), None
patent: WO 02/078693 (2002-10-01), None
patent: WO 2004/026305 (2004-04-01), None
patent: WO 2004/080996 (2004-09-01), None
patent: WO 2004/090968 (2004-09-01), None
patent: WO 2005/061442 (2005-07-01), None
patent: WO 2005/066164 (2005-07-01), None
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
J. Med. Chem, vol. 27, No. 2, pp. 129-143 (1984).
De La Torre Marta Garcia
Mitch Charles Howard
Demeter John C.
Desai Rita
Eli Lilly and Company
Ginah Francis O.
O'Dell David K
LandOfFree
Amino-phenoxymethyl-benzamide opioid receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino-phenoxymethyl-benzamide opioid receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino-phenoxymethyl-benzamide opioid receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2810682